APEIRON Biologics’ recombinant ACE2 APN01 has been selected to participate in the US ACTIV study. ACTIV is...
COVID-19
German government has launched a €300m programme designed to bring clinically tested COVID-19 treatments to...
Immunoglobin G antibodies (IgG) produced in response to the SARS-CoV-2 spike protein appear to play a role in...
Moderna Inc. has signed a COVID-19 vaccine supply agreement with vaccination alliance Gavi.
GSK's and Vir Therapeutics’ COVID-19 antibody treatment VIR-7831 has entered Phase III testing within the UK’s...
After a positive re-evaluation of J&J’s COVID-19 vaccine by the European Medicines Agency (EMA), J&J has...
A new study on the persistence of neutralising antibodies to SARS-CoV-2 in the blood suggests that humoral...
Share
